Annual EBITDA
-$19.93 M
+$4.07 M+16.97%
31 December 2023
Summary:
Eterna Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$19.93 million, with the most recent change of +$4.07 million (+16.97%) on 31 December 2023. During the last 3 years, it has fallen by -$12.78 million (-178.80%). ERNA annual EBITDA is now -178.80% below its all-time high of -$7.15 million, reached on 01 December 2020.ERNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$24.45 M
-$20.30 M-489.14%
30 September 2024
Summary:
Eterna Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$24.45 million, with the most recent change of -$20.30 million (-489.14%) on 30 September 2024. Over the past year, it has dropped by -$19.49 million (-392.15%). ERNA quarterly EBITDA is now -2366.46% below its all-time high of -$991.50 thousand, reached on 01 March 2020.ERNA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$39.07 M
-$19.49 M-99.49%
30 September 2024
Summary:
Eterna Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$39.07 million, with the most recent change of -$19.49 million (-99.49%) on 30 September 2024. Over the past year, it has dropped by -$20.47 million (-110.00%). ERNA TTM EBITDA is now -3840.70% below its all-time high of -$991.50 thousand, reached on 01 March 2020.ERNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ERNA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.0% | -392.1% | -110.0% |
| 3 y3 years | -178.8% | +71.5% | +66.4% |
| 5 y5 years | - | - | - |
ERNA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -178.8% | +83.7% | -656.4% | +71.5% | -110.0% | +68.0% |
| 5 y | 5 years | -178.8% | +83.7% | -2366.5% | +71.5% | -3840.7% | +68.0% |
| alltime | all time | -178.8% | +83.7% | -2366.5% | +71.5% | -3840.7% | +68.0% |
Eterna Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.45 M(+489.1%) | -$39.07 M(+99.5%) |
| June 2024 | - | -$4.15 M(-21.9%) | -$19.59 M(+0.6%) |
| Mar 2024 | - | -$5.32 M(+3.2%) | -$19.46 M(+0.3%) |
| Dec 2023 | -$19.93 M(-17.0%) | -$5.15 M(+3.6%) | -$19.40 M(+4.3%) |
| Sept 2023 | - | -$4.97 M(+23.4%) | -$18.61 M(-10.6%) |
| June 2023 | - | -$4.03 M(-23.4%) | -$20.82 M(+4.0%) |
| Mar 2023 | - | -$5.25 M(+20.6%) | -$20.02 M(-16.6%) |
| Dec 2022 | -$24.01 M | -$4.36 M(-39.3%) | -$24.01 M(-12.4%) |
| Sept 2022 | - | -$7.18 M(+122.1%) | -$27.40 M(-74.2%) |
| June 2022 | - | -$3.23 M(-65.0%) | -$106.06 M(-6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$9.24 M(+19.2%) | -$112.77 M(-7.5%) |
| Dec 2021 | -$121.95 M(+1605.6%) | - | - |
| Dec 2021 | - | -$7.75 M(-91.0%) | -$121.95 M(+4.8%) |
| Sept 2021 | - | -$85.84 M(+763.1%) | -$116.38 M(+257.8%) |
| June 2021 | - | -$9.95 M(-46.0%) | -$32.52 M(+32.4%) |
| Mar 2021 | - | -$18.41 M(+744.0%) | -$24.57 M(+243.7%) |
| Dec 2020 | -$7.15 M | -$2.18 M(+10.1%) | -$7.15 M(+43.9%) |
| Sept 2020 | - | -$1.98 M(-0.6%) | -$4.97 M(+66.4%) |
| June 2020 | - | -$1.99 M(+101.2%) | -$2.99 M(+201.2%) |
| Mar 2020 | - | -$991.50 K | -$991.50 K |
FAQ
- What is Eterna Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Eterna Therapeutics?
- What is Eterna Therapeutics annual EBITDA year-on-year change?
- What is Eterna Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Eterna Therapeutics?
- What is Eterna Therapeutics quarterly EBITDA year-on-year change?
- What is Eterna Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Eterna Therapeutics?
- What is Eterna Therapeutics TTM EBITDA year-on-year change?
What is Eterna Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ERNA is -$19.93 M
What is the all time high annual EBITDA for Eterna Therapeutics?
Eterna Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$7.15 M
What is Eterna Therapeutics annual EBITDA year-on-year change?
Over the past year, ERNA annual earnings before interest, taxes, depreciation & amortization has changed by +$4.07 M (+16.97%)
What is Eterna Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ERNA is -$24.45 M
What is the all time high quarterly EBITDA for Eterna Therapeutics?
Eterna Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$991.50 K
What is Eterna Therapeutics quarterly EBITDA year-on-year change?
Over the past year, ERNA quarterly earnings before interest, taxes, depreciation & amortization has changed by -$19.49 M (-392.15%)
What is Eterna Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ERNA is -$39.07 M
What is the all time high TTM EBITDA for Eterna Therapeutics?
Eterna Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$991.50 K
What is Eterna Therapeutics TTM EBITDA year-on-year change?
Over the past year, ERNA TTM earnings before interest, taxes, depreciation & amortization has changed by -$20.47 M (-110.00%)